Skip to content
Wenlo
Sign in
← Markets

Roivant Sciences Ltd.

Roivant Sciences Ltd. (ROIV) — Form 144/A: Proposed sale of shares (amendment)

144/AROIVFiled Nov 13, 2026, 5:46 PM ET

About this filing

Roivant Sciences Ltd. (ROIV) filed Form 144/A (proposed sale of shares (amendment)) with the SEC on Nov 13, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.

Key facts

Seller
RICHARD PULIK
Relationship
Officer
Shares to sell
125,000
Market value
$5,150,575.00
Approximate sale date
Nov 10, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Nov 10, 2026 · Exercise of Options Under a Registered Plan
Remarks
  1. This amendment is being filed to update the relationship to issuer.

More ROIV filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.